Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype

Clinical trials for Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype explained in plain language.

Never miss a new study

Get alerted when new Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype trials appear

Sign up with your email to follow new studies for Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Radioactive drug targets brain tumors in early trial

Disease control Recruiting now

This early-phase study tests a radioactive drug called 177Lu-PSMA-617 combined with standard chemotherapy (temozolomide) for people with aggressive IDH wild type gliomas. The goal is to see if the combination is safe and to get a first look at whether it helps control tumor growt…

Matched conditions: DIFFUSE PEDIATRIC-TYPE HIGH-GRADE GLIOMA, H3-WILDTYPE AND IDH-WILDTYPE

Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:03 UTC

Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype

Get alerted when new Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype trials appear

Radioactive drug targets brain tumors in early trial